UHS Stock Forecast 2025-2026
Distance to UHS Price Targets
UHS Price Momentum
10 Quality Stocks Worth Considering Now
Researching UHS (UHS) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on UHS and similar high-potential opportunities.
Latest UHS Stock Price Targets & Analyst Predictions
Based on our analysis of 34 Wall Street analysts, UHS has a neutral consensus with a median price target of $226.00 (ranging from $176.21 to $280.00). The overall analyst rating is Buy (7.7/10). Currently trading at $185.92, the median forecast implies a 21.6% upside. This outlook is supported by 8 Buy, 10 Hold, and 0 Sell ratings.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
UHS Analyst Ratings
UHS Price Target Range
Latest UHS Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for UHS.
Date | Firm | Analyst | Rating | Change | Price Target |
---|---|---|---|---|---|
Mar 10, 2025 | Wells Fargo | Stephen Baxter | Overweight | Maintains | $225.00 |
Feb 28, 2025 | Stephens & Co. | Scott Fidel | Equal-Weight | Maintains | $223.00 |
Feb 27, 2025 | Stephens & Co. | Raj Kumar | Equal-Weight | Reiterates | $210.00 |
Feb 27, 2025 | Barclays | Andrew Mok | Overweight | Maintains | $249.00 |
Dec 17, 2024 | JP Morgan | Benjamin Rossi | Neutral | Assumes | $226.00 |
Nov 26, 2024 | TD Cowen | Ryan Langston | Buy | Maintains | $251.00 |
Nov 25, 2024 | Wells Fargo | Stephen Baxter | Overweight | Maintains | $230.00 |
Nov 6, 2024 | Wells Fargo | Stephen Baxter | Overweight | Maintains | $285.00 |
Oct 28, 2024 | RBC Capital | Frank Morgan | Sector Perform | Maintains | $211.00 |
Oct 28, 2024 | TD Cowen | Ryan Langston | Buy | Maintains | $275.00 |
Oct 25, 2024 | Barclays | Andrew Mok | Overweight | Maintains | $271.00 |
Oct 25, 2024 | Cantor Fitzgerald | Sarah James | Neutral | Reiterates | $219.00 |
Oct 22, 2024 | Wells Fargo | Stephen Baxter | Overweight | Maintains | $275.00 |
Oct 16, 2024 | TD Cowen | Ryan Langston | Buy | Upgrade | $283.00 |
Oct 11, 2024 | Keybanc | Matthew Gillmor | Sector Weight | Initiates | $0.00 |
Oct 4, 2024 | Cantor Fitzgerald | Sarah James | Neutral | Reiterates | $219.00 |
Oct 1, 2024 | Cantor Fitzgerald | Sarah James | Neutral | Reiterates | $219.00 |
Sep 9, 2024 | RBC Capital | Ben Hendrix | Sector Perform | Maintains | $222.00 |
Sep 4, 2024 | Baird | Michael Ha | Outperform | Maintains | $274.00 |
Aug 20, 2024 | Cantor Fitzgerald | Sarah James | Neutral | Reiterates | $219.00 |
Universal Health Services Inc. (UHS) Competitors
The following stocks are similar to UHS based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Universal Health Services Inc. (UHS) Financial Data
Universal Health Services Inc. has a market capitalization of $11.80B with a P/E ratio of 10.8x. The company generates $15.83B in trailing twelve-month revenue with a 7.2% profit margin.
Revenue growth is +11.1% quarter-over-quarter, while maintaining an operating margin of +11.6% and return on equity of +17.9%.
Valuation Metrics
Growth & Margins
Financial Health
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.

Universal Health Services Inc. (UHS) Business Model
About Universal Health Services Inc.
Provides comprehensive hospital and healthcare services.
The company operates a diverse range of healthcare facilities, including acute care hospitals and behavioral health facilities, generating revenue through patient services and healthcare management. Its model focuses on meeting the increasing demand for quality medical services across various healthcare sectors.
Universal Health Services Inc. plays a significant role in the healthcare infrastructure, addressing community needs for accessible medical services. It is strategically positioned to respond to the rising demand for specialized healthcare solutions, ensuring the effective functioning of local healthcare systems.
Company Information
Sector
Healthcare
Industry
Medical Care Facilities
Employees
76,000
CEO
Mr. Marc D. Miller
Country
United States
IPO Year
1990
Website
uhs.comUniversal Health Services Inc. (UHS) Latest News & Analysis
Zacks employs the Zacks Rank system, prioritizing earnings estimates and revisions, while also monitoring value, growth, and momentum trends for stock selection.
Zacks' emphasis on earnings estimates and revisions signals potential stock performance, guiding investors toward promising opportunities in value, growth, and momentum.
UHS reports increasing admissions and patient days, indicating strong potential for future revenue growth.
Rising admissions and patient days indicate increased demand for services, suggesting potential revenue growth for UHS, which can enhance profitability and attract investor interest.
Zacks Style Scores can help investors select strong, market-beating stocks for their portfolios.
The Zacks Style Scores can help identify high-potential stocks, offering a strategic advantage in portfolio selection and potentially enhancing returns.
UNIVERSAL HEALTH SERVICES, INC. TO PRESENT AT KEYBANC CAPITAL MARKETS VIRTUAL HEALTHCARE FORUM
14 days agoUniversal Health Services, Inc. (NYSE: UHS) CFO Steve Filton will speak at the KeyBanc Capital Markets Virtual Healthcare Forum on March 18, 2025, from 11:15am to 11:50am EST.
Filton's participation in the forum may provide insights into UHS's financial health and strategic direction, influencing investor sentiment and stock performance.
The S&P 500 fell 4.2% over the past month, marking its worst week since September, potentially creating buying opportunities for NVDA, UHS, UAL, CCL, and SYF.
The S&P 500's decline signals market volatility, potentially impacting investor sentiment. The drop may present attractive entry points for specific stocks like NVDA, UHS, UAL, CCL, and SYF.
Universal Health Services (UHS) reported 11% annual EPS growth but faced stock decline due to Medicaid cut concerns. It operates 419 hospitals, with 25% of revenue from Medicaid.
UHS's steady EPS growth contrasts with stock declines linked to Medicaid cut fears, impacting revenue from its significant Medicaid exposure. This uncertainty could affect future valuations.
Frequently Asked Questions About UHS Stock
What is Universal Health Services Inc.'s (UHS) stock forecast for 2025?
Based on our analysis of 34 Wall Street analysts, Universal Health Services Inc. (UHS) has a median price target of $226.00. The highest price target is $280.00 and the lowest is $176.21.
Is UHS stock a good investment in 2025?
According to current analyst ratings, UHS has 8 Buy ratings, 10 Hold ratings, and 0 Sell ratings. The stock is currently trading at $185.92. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for UHS stock?
Wall Street analysts predict UHS stock could reach $226.00 in the next 12 months. This represents a 21.6% increase from the current price of $185.92. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Universal Health Services Inc.'s business model?
The company operates a diverse range of healthcare facilities, including acute care hospitals and behavioral health facilities, generating revenue through patient services and healthcare management. Its model focuses on meeting the increasing demand for quality medical services across various healthcare sectors.
What is the highest forecasted price for UHS Universal Health Services Inc.?
The highest price target for UHS is $280.00 from at , which represents a 50.6% increase from the current price of $185.92.
What is the lowest forecasted price for UHS Universal Health Services Inc.?
The lowest price target for UHS is $176.21 from at , which represents a -5.2% decrease from the current price of $185.92.
What is the overall UHS consensus from analysts for Universal Health Services Inc.?
The overall analyst consensus for UHS is neutral. Out of 34 Wall Street analysts, 8 rate it as Buy, 10 as Hold, and 0 as Sell, with a median price target of $226.00.
How accurate are UHS stock price projections?
Stock price projections, including those for Universal Health Services Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.